HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Friedhelm Dapper Johannes Kroll Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Dapper, F. Articles by Schranz, D. Search for Related Content PubMed PubMed Citation Articles by Dapper, F. Articles by Schranz, D.

Eur J Cardiothorac Surg 1998;14:1-6
© 1998 Elsevier Science NL

Clinical experience with heart transplantation in infants¹

^a Department of Cardiovascular Surgery, Justus-Liebig-University, D-35385 Giessen, Germany
^b Department of Pediatric Cardiology; Justus-Liebig-University, D-35385 Giessen, Germany
^c Department of Anesthesiology and Intensive Care Medicine, Justus-Liebig-University, D-35385 Giessen, Germany
^d Department of Pathology, Justus-Liebig-University, D-35385 Giessen, Germany

Received 26 November 1997; received in revised form 9 March 1998; accepted 15 April 1998.

Corresponding author. Tel.: +49 40 47172440; fax: +49 40 47174931; e-mail: dapper@uke.uni-hamburg.de

Objective: Orthotopic heart transplantation has become an accepted therapeutic concept for adult patients with endstage heart disease. In newborns and infants this procedure is still a matter of discussion because of unknown long-term results and the lack of donor organs. Methods: Since March 1988 we have performed 40 orthotopic heart transplantation in 39 infants who were from 1 to 280 days of age. Indications for transplantation included hypoplastic left-heart syndrome (n=28), dilative cardiomyopathy (n=4), endocardial fibroelastosis (n=4) and other complex structural anomalies (n=3). The mean waiting period for transplantation was 53 days. A donor–recipient weight ratio up to 4.0 was accepted. Profound hypothermic circulatory arrest was used for graft implantation in all those patients who required extensive aortic arch reconstruction (71%). The initial immunomodulation was based on Cyclosporine, Azathioprine and Prednisolone. Patients who underwent transplantation during the first 6 weeks of life received a chronic single-drug therapy with Cyclosporine after 1 year. Results: There were six peri-operative deaths caused by drug-resistant right-heart failure in three cases, humoral rejection (n=1), CMV infection (n=1) and multi organ failure (n=1). One infant died late, due to rejection. The actuarial survival rate for the entire group is now 82%. There is a remarkable influence of increasing experience. Whereas six of 15 infants who had heart transplantation between 1988 and 1993 died early post-operatively (survival rate: 60%), only one late death occurred among 24 recipients in the period from 1994 to April 1997 (survival rate: 96%). Episodes of rejection occurred once or several times in about half of the patients in this series (48%). All surviving children are living at home in excellent condition. Conclusions: Heart transplantation during early infancy is a rational and durable therapy for heart diseases with irreversible myocardial failure or severe structural anomalies. The intermediate-term results have been encouraging in many centers, but more data must be accumulated to determine the sequelae of chronic immunosuppression. The lack of donor organs remains one of the major problems in pediatric heart transplantation.

Key Words: Heart transplantation • Infants • Rejection • Somatic development • Long-term results

This article has been cited by other articles:

				C.-P. Lin, K.-C. Chan, Y.-M. Chou, M.-J. Wang, and S.-K. Tsai Transoesophageal echocardiographic monitoring of pulmonary venous obstruction induced by sternotomy closure during infant heart transplantation Br. J. Anaesth., April 1, 2002; 88(4): 590 - 592. [Abstract] [Full Text] [PDF]

				L. J. West, S. M. Pollock-Barziv, A. I. Dipchand, K. J. Lee, C. J. Cardella, L. N. Benson, I. M. Rebeyka, and J. G. Coles ABO-Incompatible Heart Transplantation in Infants N. Engl. J. Med., March 15, 2001; 344(11): 793 - 800. [Abstract] [Full Text] [PDF]

				T. R. Cooper, J. A. Garcia-Prats, and B. A. Brody Managing Disagreements in the Management of Short Bowel and Hypoplastic Left Heart Syndrome Pediatrics, October 1, 1999; 104(4): 48e - 48. [Abstract] [Full Text]

				H. Akintuerk, I. Michel-Behnke, K. Valeske, M. Mueller, J. Thul, J. Bauer, K.-J. Hagel, J. Kreuder, P. Vogt, and D. Schranz Stenting of the Arterial Duct and Banding of the Pulmonary Arteries: Basis for Combined Norwood Stage I and II Repair in Hypoplastic Left Heart Circulation, March 5, 2002; 105(9): 1099 - 1103. [Abstract] [Full Text] [PDF]